tiprankstipranks
Trending News
More News >
Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ:AVIR
US Market

Compare Atea Pharmaceuticals (AVIR) vs. Competitors

Compare
243 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Atea Pharmaceuticals
$4.08
$320.32M
-2.26
28.85%
2 Buy
0 Hold
0 Sell
Moderate Buy
Codexis
$1.32
$119.23M
-1.69
-70.34%
2 Buy
2 Hold
0 Sell
Moderate Buy
Heron Therapeutics
$1.32
$242.04M
-14.96
-27.07%
2 Buy
0 Hold
0 Sell
Moderate Buy
ProQR
$1.55
$163.29M
-3.20
-29.55%
4 Buy
0 Hold
0 Sell
Strong Buy
Tiziana Life Sciences
$1.37
$164.02M
-11.11
92.42%
OmniAb
$1.74
$250.48M
-2.79
-53.65%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AVIR
Atea Pharmaceuticals
4.02
0.92
29.68%
CDXS
Codexis
1.32
-3.07
-69.93%
HRTX
Heron Therapeutics
1.32
-0.47
-26.26%
PRQR
ProQR
1.55
-0.85
-35.42%
TLSA
Tiziana Life Sciences
1.27
0.63
98.44%
OABI
OmniAb
1.65
-2.06
-55.53%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts